Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real-world observational analysis of a health claims database
2018 ◽
Vol 20
(10)
◽
pp. 2351-2360
◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 16
(9)
◽
pp. 567-575
◽
Keyword(s):
2019 ◽
Vol 29
(9)
◽
pp. 923-930
◽
2020 ◽
Vol 11
(5)
◽
pp. 1170-1180
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):